256 related articles for article (PubMed ID: 28119061)
41. Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A.
Arozarena I; Sanchez-Laorden B; Packer L; Hidalgo-Carcedo C; Hayward R; Viros A; Sahai E; Marais R
Cancer Cell; 2011 Jan; 19(1):45-57. PubMed ID: 21215707
[TBL] [Abstract][Full Text] [Related]
42. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
[TBL] [Abstract][Full Text] [Related]
43. Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429.
Sun Y; Hou Z; Luo B; Li C; Liu J; Liu J; Tang J; Yao G
Bioengineered; 2021 Dec; 12(1):4159-4173. PubMed ID: 34288815
[TBL] [Abstract][Full Text] [Related]
44. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
[TBL] [Abstract][Full Text] [Related]
45. TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.
Peres J; Damerell V; Chauhan J; Popovic A; Desprez PY; Galibert MD; Goding CR; Prince S
J Invest Dermatol; 2021 Sep; 141(9):2250-2260.e2. PubMed ID: 33744299
[TBL] [Abstract][Full Text] [Related]
46. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.
Dadras SS; Lin RJ; Razavi G; Kawakami A; Du J; Feige E; Milner DA; Loda MF; Granter SR; Detmar M; Widlund HR; Horstmann MA; Fisher DE
Am J Pathol; 2015 Jan; 185(1):252-65. PubMed ID: 25447045
[TBL] [Abstract][Full Text] [Related]
47. Peptide L13S Derived from the BRN2 POU Domain Reduces Metastasis
Cesar MCM; Mortara RA; Souza VS; Alves VRG; Paschoalin T; Soufen MA; DE Freitas GM; DA Cunha FFM; Tada DB; Dobroff AS; Arruda DC
Anticancer Res; 2024 Jan; 44(1):71-84. PubMed ID: 38160013
[TBL] [Abstract][Full Text] [Related]
48. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
Grabacka M; Placha W; Urbanska K; Laidler P; Płonka PM; Reiss K
Pigment Cell Melanoma Res; 2008 Jun; 21(3):388-96. PubMed ID: 18444964
[TBL] [Abstract][Full Text] [Related]
49. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.
Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J
BJU Int; 2016 Feb; 117(2):351-62. PubMed ID: 24612432
[TBL] [Abstract][Full Text] [Related]
50. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
51. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
[TBL] [Abstract][Full Text] [Related]
52. Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells.
Leclerc J; Garandeau D; Pandiani C; Gaudel C; Bille K; Nottet N; Garcia V; Colosetti P; Pagnotta S; Bahadoran P; Tondeur G; Mograbi B; Dalle S; Caramel J; Levade T; Ballotti R; Andrieu-Abadie N; Bertolotto C
Oncogene; 2019 Feb; 38(8):1282-1295. PubMed ID: 30254208
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneous tumor subpopulations cooperate to drive invasion.
Chapman A; Fernandez del Ama L; Ferguson J; Kamarashev J; Wellbrock C; Hurlstone A
Cell Rep; 2014 Aug; 8(3):688-95. PubMed ID: 25066122
[TBL] [Abstract][Full Text] [Related]
54. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
[TBL] [Abstract][Full Text] [Related]
55. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
[TBL] [Abstract][Full Text] [Related]
56. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.
Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152
[TBL] [Abstract][Full Text] [Related]
57. Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.
Bianchi-Smiraglia A; Bagati A; Fink EE; Moparthy S; Wawrzyniak JA; Marvin EK; Battaglia S; Jowdy P; Kolesnikova M; Foley CE; Berman AE; Kozlova NI; Lipchick BC; Paul-Rosner LM; Bshara W; Ackroyd JJ; Shewach DS; Nikiforov MA
Oncogene; 2017 Jan; 36(1):84-96. PubMed ID: 27181209
[TBL] [Abstract][Full Text] [Related]
58. miR-148 regulates Mitf in melanoma cells.
Haflidadóttir BS; Bergsteinsdóttir K; Praetorius C; Steingrímsson E
PLoS One; 2010 Jul; 5(7):e11574. PubMed ID: 20644734
[TBL] [Abstract][Full Text] [Related]
59. An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
Perotti V; Baldassari P; Molla A; Nicolini G; Bersani I; Grazia G; Benigni F; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2019 May; 38(22):4384-4396. PubMed ID: 30710146
[TBL] [Abstract][Full Text] [Related]
60. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]